Prognostic factors in patients with esophageal carcinoma treated with chemoradiation: Single center experience

Hepato-Gastroenterology

Volumn 57, Issue 102-103, 2010, Pages 1145-1149

  Cincibuch, Jan ^a   Neoral, Čestmir ^a   Aujeský, René ^a   Šrámek, Vlastislav ^a   Schneiderka, Petr ^a   Študentová, Hana ^a   Melichar, Bohuslav ^a   Kohoutek, Milan ^a   Strážnická, Jana ^a   Vrba, Radek ^a   Juráňová, Jarmila ^a   Flodr, Patrik ^a   Macháček, Jindřich ^a   Cwiertka, Karel ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Chemoradiation; Esophageal carcinoma; Prognosis

Indexed keywords

ALBUMIN; CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; WEIGHT REDUCTION;

EID: 79251591025     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kollarova H, Machova L, Horakova D, Janoutova G, Janout V: Epidemiology of esophageal cancer - an overview article. Biomed Pap Med Fac Univ Palacky 2007; 151:17-28.
2. Orringer MB, Marshall B, Chang AC, Lee J, Pickens A, Lau CL: Two thousand transhiatal esophagectomies. Changing trends, lessons learned. Ann Surg 2007; 246:363-374.
3. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugerbaker D, Mayer R: Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26:1086-1092.
4. Mariette C, Balon JM, Piessen G, Fabre S, Seuningen I, Triboulet JP: Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 2003; 97:1616-1623.
5. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, Lozach P, Chaillard G, Ollier JC, Pavy JJ, Mercier MTS: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337:161-167.
6. Walsh TN, Nooman N, Hollywood D, Kelly A, Stat C, Keeling N, Hennessy PJ: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335:462-467.
7. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Straederman M: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19:305-313.
8. Thomas CR, Berkey BA, Minsky BD, Gaspar LE, Herskovic A, Rich TA, Gunderson LL: Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys 2004; 58:1405-1410.
9. Di Fiore F, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, Ducrotte P, Lerebours E, Michel P: Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 2007; 102:2557-2563.
10. Siewert JR, Stein HJ, Feith M, Bruecher BLDM, Bartels H, Fink U: Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the western world. Ann Surg 2001; 234:360-369.
11. Rades D, Schild SE, Bahrehmad R, Zschenker O, Alberti WA, Rudat VR: Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy. Cancer 2005; 103:1740-1746.
12. Valencia Julve J, Alonso Orduna V, Esco Baron R, Lopez-Mata M, Mendez Villamon A: Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy. Clin Transl Oncol 2006; 8:22-30.
13. Shimada H, Okazumi SI, Matsubara H, Nabeya Y, Takeda A, Gunji I, Ochiai T: Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. J Am Coll Surg 2004; 198:737-741.
14. Kleinberg L, Knisely PS, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA: Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 2003; 56:328-334.
15. Reynolds JV, Muldoon C, Hollywood D, Ravi N, Rowley S, O Byrne K, Kennedy J, Murphy TJ: Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg 2007; 245:707-716. (Pubitemid 46684100)
16. Schneider PM, Baldus SE, Metzger R, Kocher M, Bongartz R, Bollschweiler E, Schaefer H, Thiele J, Dienes HP, Mueller RP, Hoelscher AH: Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer. Ann Surg 2005; 242:684-692.
17. Guillem P, Triboulet JP: Elevated serum levels of C-reactive protein are indicative of a poor prognosis in patients with esophageal cancer. Dis Esophagus 2005; 18:146-150.
18. Cincibuch J, Melichar B, Studentova H, Kapustova M, Malirova E, Solichova D, Krcmova L, Kasparova M, Schneiderka P, Juranova J, Sramek V, Cwiertka K: Serum neopterin, retinol and alpha-tocopherol in patients with the carcinoma of the esophagus. Pteridines 2009; 20:11-15.
19. Kelsen DP, Winter KA, Gunderson LL, Mortimer J, Estes NC, Haller DG, Ajani JA, Kocha W, Minsky BD, Roth JA, Willett C: Long-term results of RTOG trial (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 2007; 25:3719-3725.